首页> 外文期刊>Journal of Clinical Pathology >Immunohistochemical quantitation of oestrogen receptors and proliferative activity in oestrogen receptor positive breast cancer.
【24h】

Immunohistochemical quantitation of oestrogen receptors and proliferative activity in oestrogen receptor positive breast cancer.

机译:雌激素受体阳性乳腺癌中雌激素受体的免疫组织化学定量和增殖活性。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM--To evaluate the effect of the duration of formalin fixation and of tumour heterogeneity on quantitative estimates of oestrogen receptor content (oestrogen receptor index) and proliferative activity (MIB-1 index) in breast cancer. METHODS--Two monoclonal antibodies, MIB-1 and oestrogen receptor, were applied to formalin fixed, paraffin wax embedded tissue from 25 prospectively collected oestrogen receptor positive breast carcinomas, using a microwave antigen retrieval method. Tumour tissue was allocated systematically to different periods of fixation to ensure minimal intraspecimen variation. The percentages of MIB-1 positive and oestrogen receptor positive nuclei were estimated in fields of vision sampled systematically from the entire specimen and from the whole tumour area of one "representative" cross-section. RESULTS--No correlation was found between the oestrogen receptor and MIB-1 indices and the duration of formalin fixation. The estimated MIB-1 and oestrogen receptor indices in tissue sampled systematically from the entire tumour were closely correlated with estimates obtained in a "representative" section. The intra- and interobserver correlation of the MIB-1 index was good, although a slight systematical error at the second assessment of the intraobserver study was noted. CONCLUSION--Quantitative estimates of oestrogen receptor content and proliferative activity are not significantly influenced by the period of fixation in formalin, varying from less than four hours to more than 48 hours. The MIB-1 and the oestrogen receptor indices obtained in a "representative" section do not deviate significantly from average indices determined in tissue samples from the entire tumour. Finally, the estimation of MIB-1 index is reproducible, justifying its routine use.
机译:目的-评估福尔马林固定持续时间和肿瘤异质性对乳腺癌中雌激素受体含量(雌激素受体指数)和增殖活性(MIB-1指数)的定量估计的影响。方法-用微波抗原提取方法将两种单克隆抗体MIB-1和雌激素受体应用于来自25个前瞻性收集的雌激素受体阳性乳腺癌的福尔马林固定石蜡包埋组织中。系统地将肿瘤组织分配到不同的固定期,以确保最小的标本内变异。从整个标本和一个“代表性”横截面的整个肿瘤区域系统地采样视野中,估计了MIB-1阳性和雌激素受体阳性细胞核的百分比。结果-雌激素受体和MIB-1指数与福尔马林固定持续时间之间没有相关性。从整个肿瘤系统取样的组织中估计的MIB-1和雌激素受体指数与“代表性”部分中获得的估计密切相关。尽管在观察者内研究的第二次评估中发现了轻微的系统性错误,但MIB-1指数的观察者内和观察者间相关性良好。结论-福尔马林固定期间的雌激素受体含量和增殖活性的定量估计值不受显着影响,范围从少于4小时到超过48小时不等。在“代表性”部分中获得的MIB-1和雌激素受体指数与整个肿瘤的组织样本中确定的平均指数没有显着偏离。最后,MIB-1指数的估计是可重现的,证明了它的常规用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号